OMGA Omega Therapeutics
- 1.790
- -0.050-2.72%
- 1.850
- +0.060+3.35%
Omega Therapeutics News
Omega Therapeutics | 8-K: Current report
Omega Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Boehm Rainer J.
Omega Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Szela Mary T
Omega Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director SCHADE CHRISTIAN S
Omega Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director MENDLEIN JOHN
Omega Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Levy Elliott M.
Omega Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Kender Richard N
Omega Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Werner Michelle C
Omega Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Young Richard A
Omega Therapeutics | 3: Initial statement of beneficial ownership of securities-Director Kender Richard N
Omega Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Certel Kaan
Omega Therapeutics | 3: Initial statement of beneficial ownership of securities-Officer Certel Kaan
Omega Therapeutics | 3: Initial statement of beneficial ownership of securities-Officer Chan Barbara Y
Omega Therapeutics | 8-K/A: Current report (Amendment)
Omega Therapeutics | 8-K: Current report
Omega Therapeutics | 10-Q: Quarterly report
Omega Therapeutics | 8-K: Omega Therapeutics Reports First Quarter 2024 Financial Results and Highlights Recent Company Progress
Omega Therapeutics | DEFA14A: Others
Omega Therapeutics | DEF 14A: Definitive information statements
Omega Therapeutics | PRE 14A: Preliminary proxy statements relating to merger or acquisition
Analysis
Price Target
No Data
